ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,705.00
-0.20 (-0.01%)
Last Updated: 12:22:30
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.01% 1,705.00 1,705.00 1,705.40 1,709.60 1,699.40 1,701.60 993,385 12:22:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.3B

GlaxoSmithKline PLC Re Directorate (0001V)

22/10/2014 12:12pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 0001V

GlaxoSmithKline PLC

22 October 2014

Change to Director's Details - Dr Moncef Slaoui

GlaxoSmithKline plc (the "Company") today confirms that Dr Moncef Slaoui, an Executive Director, is appointed Chairman, Vaccines, with immediate effect.

This appointment will ensure more focused management of the Company's Vaccines business in advance of the completion of the proposed 3 part transaction with Novartis announced earlier this year. Dr Slaoui will continue to provide scientific and technical counsel on pharmaceutical R&D activities to the CEO and Board.

Dr Slaoui was previously Chairman, Global R&D and Vaccines.

V A Whyte

Company Secretary

22 October 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAFEWFFEFLSESS

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock